Concepedia

Kai-Uwe Jarr

KJ

Statistics

Publications

9

Citations

672

H-Index

9

Active since

2011

Affiliations

Cardiovascular Institute of the South(Current)

Stanford University

German Centre for Cardiovascular Research

Heidelberg University

TUM Klinikum

Kai-Uwe Jarr is an author at Cardiovascular Institute of the South specializing in life sciences, gene expression, and molecular biology.

ORCID

Publications per year

2011–2025

9

Publications

9

Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis

Alyssa M. Flores, Niloufar Hosseini-Nassab, Kai-Uwe Jarr et al. · Nature Nanotechnology · 2020 · 283 citations · Full text

, , +16

Clonally expanding smooth muscle cells promote atherosclerosis by escaping efferocytosis and activating the complement cascade

Ying Wang, Vivek Nanda, Daniel DiRenzo et al. · Proceedings of the National Academy of Sciences · 2020 · 130 citations · Full text

, , +17

MicroRNA-20a inhibits stress-induced cardiomyocyte apoptosis involving its novel target Egln3/PHD3

Derk Frank, Johanne Gantenberg, Inka Boomgaarden et al. · Journal of Molecular and Cellular Cardiology · 2011 · 81 citations

, , +13

The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis

Kai-Uwe Jarr, Jianqin Ye, Yoko Kojima et al. · Nature Cardiovascular Research · 2022 · 54 citations · Full text

, , +14

Chitinase 3 like 1 is a regulator of smooth muscle cell physiology and atherosclerotic lesion stability

Pavlos Tsantilas, Shen Lao, Zhiyuan Wu et al. · Cardiovascular Research · 2021 · 38 citations · Full text

, , +16

1–5 of 9